Mylan (MYL -0.4%) says its partner Famy Care has received final FDA approval for its Abbreviated...

|About: Mylan Inc (MYL)|By:, SA News Editor

Mylan (MYL -0.4%) says its partner Famy Care has received final FDA approval for its Abbreviated New Drug Application for Levonorgestrel and Ethinyl Estradiol Tablets, a generic version of Teva Pharmaceutical's (TEVA +0.6%) contraception product Nordette. MYL plans to begin shipping the product immediately.